Refining letermovir prophylaxis strategies and CD4 + T cell-guided discontinuation in aplastic anemia patients post-allogeneic HSCT: a retrospective analysis

Abstract Introduction Cytomegalovirus (CMV) infection is a significant complication in aplastic anemia (AA) patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT). While letermovir has shown efficacy in CMV prophylaxis, the optimal timing for discontinuing letermovir rema...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Yuling Zhang, Xiaoqing He, Ming Zhou, Yuping Zhang, Wenjian Mo, Ruiqing Zhou, Yumiao Li, Qi Xiang, Fangfang Yang, Shilin Xu, Caixia Wang, Wei Zhou, Tingfen Deng, Shiyi Pan, LiangLiang Wu, Shunqing Wang, Xiaowei Chen
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	BMC 2026-01-01
Seri Bilgileri:	European Journal of Medical Research
Konular:	Letermovir Aplastic anemia Allogeneic hematopoietic stem cell transplantation Cytomegalovirus infections
Online Erişim:	https://doi.org/10.1186/s40001-025-03794-8
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!